UCSF researchers have used a zebrafish screen to identify an adenosine receptor agonist that improved both beta cell regeneration and glucose control in diabetic mice. The discovery could open up a new indication for a class of compounds that until now have been developed mainly for inflammatory and cardiovascular disorders.